Cannvas.me Cannabis Platform Leverages IBM Watson Technology

Platform Creating Unique Omni-Channel Customer Journey

TORONTO, Sept. 4, 2018 /CNW/ - Cannvas MedTech Inc. ("Cannvas" or the "Company") (CSE: MTEC) (Frankfurt: 3CM), a leading business technology company in the cannabis space, is pleased to announce its vendor of choice for integration to its Artificial Intelligence (A.I) component powering the Cannvas.me cannabis education platform.

IBM Watson has been chosen to power the A.I. analytics branch of the Cannvas platform.  It will  serve as a best-in-class integrated solution most relevant and attuned for the persona-driven architecture of the platform.  Leveraging IBMs A.I. service allows the Cannvas team to quickly analyze through the copious amounts of data attributes comprising the Cannvas.me platform in a relevant and real-time fashion for its user base.

Deriving industry and customer insights in a real-time fashion for the CRM program requires the use of technologies that are at the leading edge of their space.  Utilizing IBM Watsons capabilities allows the Cannvas technology stack to achieve this goal.   Cannvas.me takes the traditional Email Customer Journey and transforms it into a true Omni-Channel approach where user preferences and insights are utilized to serve a fully personalized message experience through the channel of their choice.  Cannvas.me will be able to truly embrace the concept of Omni-Channel marketing.

Having a data technology solution that is recognized as a leader in its space allows the Cannvas team to utilize years of A.I. advancements that the IBM team has been pushing forth within the field. 

About Cannvas MedTech Inc.

Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.

For additional information:
www.cannvasmedtech.com

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.  For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company's Management's Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.

SOURCE Cannvas MedTech Inc.

Media Inquiries: [email protected]; Investor Relations: [email protected], 1-800-489-0116